Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • English
    • Deutsch
    • Français
    • Italiano
    • Português
    • Español
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Breast Cancer

Overweight and diabetes unfavorable for therapy success

    • Congress Reports
    • Gynecology
    • Oncology
    • Partner Content
    • RX
  • 2 minute read

Diabetes mellitus and obesity have long been recognized as cardiovascular risk factors. They also have a negative effect on breast cancer patients: Compared to metabolically healthy and normal-weight patients, the risk of recurrence after neoadjuvant chemotherapy is increased, as is the risk of death in diabetic women.

(ka) The new data come from an analysis of a total of 10,727 breast cancer patients. 8872 of them were treated in German Breast Group trials, 1855 in EORTC/Breast International Group (BIG) trials, informed Caterina Fontanella, MD, Udine, Italy [1]. Only half of these women were of normal weight, 30% were overweight, and 20% were even obese.

With increasing body weight, the 5-year rate for distant metastasis-free survival decreased linearly. This was true for women with luminal A/B subtype tumors (n=3977) and for women with triple-negative breast cancer (TNBC; n=1570). In the first group, the worsening of prognosis in overweight women is probably due to increased aromatase levels in adipose tissue. This increases the synthesis of estrogen, which stimulates the growth of breast cancer cells. In women with TNBC, the poorer treatment outcomes may be due in part to the increased levels of proinflammatory cytokines associated with obesity, Dr. Fontanella explained. “Secondly, it must be taken into account that obese patients probably receive chemotherapy doses that are too low. This is because doses of cytostatic drugs are usually calculated on a body surface area (KOF) of 2 m². In obese women, however, a larger KOF can be assumed.”

Special case HER2-negative

Only in patients with HER2-negative breast cancer (n=2418) no negative effect of obesity on treatment outcome could be determined. According to Dr. Fontanella, this is probably due to the markedly potent antitumor effect of anti-HER2 therapy.

Type 2 diabetes as a comorbidity

In the second evaluation, Dr. Fontanella and associates examined the prevalence of type 2 diabetes among participants in the GeparQuatro and GeparQuinto trials at the time of breast cancer diagnosis and the impact of this comorbidity on treatment outcomes. In this cohort, 112 patients (2.8%) had type 2 diabetes; only one-third received antidiabetic therapy. Diabetic patients were older than nondiabetic patients (61 vs. 49 years), more often obese (52 vs. 18%), and more often had more than two comorbidities (51 vs. 12%). Diabetic patients were also more likely than non-diabetic patients to already have a locally advanced tumor at diagnosis (28 vs. 14%) and more than three affected lymph nodes (14 vs. 5%). In addition, distant metastasis-free and overall survival were significantly shorter in diabetic patients than in metabolically healthy women (p<0.001 and p=0.001, respectively). Their risk of recurrence was significantly increased by a factor of 2 (p<0.001).

Hyperinsulinemia as a cause

According to Dr. Fontanella, the cause of higher tumor stage and poorer therapy results in diabetic women could be hyperinsulinemia, since the increased insulin level stimulates tumor cell growth. Tight glycemic control is therefore essential in this population to improve therapeutic outcome.

Source: European Breast Cancer Conference (EBCC) 9, March 19-21, 2014, Glasgow.

Literature:

  1. Fontanelle C, et al: EBCC 9; Abstr. O-417.

InFo ONCOLOGY & HEMATOLOGY 2014; 2(4): 21-22.

Autoren
  • Dr. med. Katharina Arnheim
Publikation
  • InFo ONKOLOGIE & HÄMATOLOGIE
Related Topics
  • Adipostias
  • Breast Cancer
  • chemotherapy
  • Cytostatics
  • Diabetes
  • distant metastasis-free survival
  • Estrogen
  • Glasgow
  • HER2
  • KOF
  • Luminal
  • Mortality risk
  • Overweight
  • Risk of recurrence
  • Therapy
  • Tumor
Previous Article
  • Gender Dysphoria

Clarification and treatment recommendations

  • Education
  • Psychiatry and psychotherapy
  • RX
View Post
Next Article
  • Iron deficiency

One finding, different patients

  • Cardiology
  • Congress Reports
  • Endocrinology and Diabetology
  • Hematology
  • RX
View Post
You May Also Like
View Post
  • 6 min
  • Case Report

Breast cancer metastases in the bladder

    • Cases
    • Education
    • Gynecology
    • Oncology
    • RX
    • Urology
View Post
  • 11 min
  • Findings from the ALS Symposium 2024 in Montreal

Current and future approaches in the treatment of amyotrophic lateral sclerosis (ALS)

    • Congress Reports
    • Interviews
    • Neurology
    • RX
    • Studies
View Post
  • 8 min
  • Efficacy, mechanism of action and clinical effects

Garlic and high blood pressure

    • Cardiology
    • Education
    • General Internal Medicine
    • Pharmaceutical medicine
    • Phytotherapy
    • RX
    • Studies
View Post
  • 7 min
  • Moderate to severe chronic hand eczema

Delgocitinib cream – first topical pan-JAK inhibitor approved in Switzerland

    • Allergology and clinical immunology
    • Dermatology and venereology
    • Education
    • Infectiology
    • Market & Medicine
    • Pharmacology and toxicology
    • RX
View Post
  • 9 min
  • Wild-type transthyretin amyloid cardiomyopathy (ATTRwt-CA)

Diagnosis at an early stage, prognostic classifications and outlook

    • Cardiology
    • Education
    • RX
    • Studies
View Post
  • 4 min
  • Case report: Drug-induced hepatitis

Rare side effect of tirzepatide therapy

    • Cases
    • Education
    • Endocrinology and Diabetology
    • Gastroenterology and Hepatology
    • Pharmacology and toxicology
    • RX
    • Studies
View Post
  • 4 min
  • Plea for sex-specific neurology

Migraine in men: underdiagnosed, underestimated, under-researched

    • Education
    • Neurology
    • RX
    • Studies
View Post
  • 4 min
  • Prurigo nodularis

Retrospective analyses of large data sets from everyday practice

    • Allergology and clinical immunology
    • Congress Reports
    • Dermatology and venereology
    • RX
Top Partner Content
  • Forum Gastroenterology

    Zum Thema
  • Herpes zoster

    Zum Thema
  • Dermatology News

    Zum Thema
Top CME content
  • 1
    Patience, knowledge and persistence in therapy
  • 2
    Sarcopenia and malnutrition in the context of pneumological rehabilitation
  • 3
    Medical and psychosocial perspectives
  • 4
    New nomenclature for non-alcoholic fatty liver disease
  • 5
    Examinations and considerations before therapy

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.